Role of glucoxidation and lipid oxidation in the development of atherosclerosis.
Previous data have indicated that modification of proteins/lipids by glucoxidation and/or lipid oxidation may initiate/propagate the formation of atherosclerotic plaques. Although the biomarker carboxymethyllysine (CML) has been detected in these lesions, the origin of the reactive oxygen species (ROS) leading to its formation and the source of its carbon backbone are unknown. As presented here, the stimulation of cultured monocytes by phorbol-12-myristate-13-acetate (TPA), an activator of protein kinase C that can mimic the effects of high glucose, angiotensin II, and other physiological stimuli, leads to cellular ROS generation and concomitant formation of intracellular CML. Inhibitors of ROS-generating cellular systems such as NO synthase, xanthine oxidase, or cytochrome P450 oxidase had no effect on CML formation. Likewise, in cells with inactive NAD(P)H oxidase no reduced CML formation was found. In cells exhibiting a high glycolysis rate, CML formation was unaffected. Because we found rapid CML formation in the presence of unsaturated fatty acids, it appears that lipid oxidation is quantitatively more important. In vivo studies revealed strong intracellular CML staining in areas of histiocytic/monocytic infiltration or proliferation, mostly associated with atheroma formation. Corresponding CML staining patterns were found in healing wounds of different ages, indicating that formation of atherosclerosis is a chronic wound repair associated with a low-grade inflammatory reaction. In summary, CML is formed concomitantly with oxidative stress in activated monocytes and can be regarded as a biomarker for a low-grade inflammatory tissue reaction in the atherosclerotic plaque. Its formation via lipid oxidation may be involved in the development of atherosclerosis.
Schleicher
Erwin
E
Department of Internal Medicine (Endocrinology, Metabolism and Clinical Chemistry), University of Tübingen, Otfried-Müller-Str. 10, D-72076 Tübingen, Germany. enschlei@med.uni-tuebingen.de
Weigert
Cora
C
Rohrbach
Helmut
H
Nerlich
Andreas
A
Bachmeier
Beatrice
B
Friess
Ulrich
U
D001161:Arteriosclerosis / Q000473:pathology / Q000503:physiopathology*; D002460:Cell Line; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007249:Inflammation; D015227:Lipid Peroxidation; D008239:Lysine / Q000031:analogs & derivatives; D009000:Monocytes / Q000187:drug effects / Q000502:physiology*; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects; D011493:Protein Kinase C / Q000097:blood; D012260:Ribonucleases / Q000097:blood; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014945:Wound Healing / Q000502:physiology*
D011493:Protein Kinase C; D012260:Ribonucleases; D005947:Glucose; D008239:Lysine; D013755:Tetradecanoylphorbol Acetate